GABAergic mechanisms are involved in the antihyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory hyperalgesia

Pharmacology

Volumn 82, Issue 1, 2008, Pages 53-58

  Stepanović Petrović, Radica M ^a,c   Tomić, Maja A ^a   Vučković, Sonja M ^a   Kocev, Nikola ^a   Ugrešić, Nenad D ^a   Prostran, Milica Š ^a   Bošković, Bogdan ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c Faculty of Pharmacy   (Serbia)

Author keywords

Bicuculline; Carbamazepine; Inflammatory hyperalgesia; Oxcarbazepine; Paw pressure test

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BICUCULLINE; CARBAMAZEPINE; CONCANAVALIN A; OXCARBAZEPINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; GABAERGIC SYSTEM; HYPERALGESIA; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS, NON-NARCOTIC; ANIMALS; ANTICONVULSANTS; BICUCULLINE; CARBAMAZEPINE; CONCANAVALIN A; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA ANTAGONISTS; GABA MODULATORS; HYPERALGESIA; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; MALE; PAIN THRESHOLD; RATS; RATS, WISTAR; RECEPTORS, GABA-A;

EID: 46449128393     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000127841     Document Type: Article

References (23)

1. Rang HP, Dale MM, Ritter JM, Flower RJ: Antiepileptic drugs; in Pharmacology, ed 6. Edinburgh, Churchill Livingstone, 2007, pp 575-587.
2. Bianchi M, Rossoni G, Sacerdote P, Panerai AE, Berti F: Carbamazepine exerts anti-inflammatory effects in the rat. Eur J Pharmacol 1995;294:71-74.
3. Kiguchi S, Imamura T, Ichikawa K, Kojima M: Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy. Clin Exp Pharmacol Physiol 2004;31:57-64.
4. Tomić MA, Vučković SM, Stepanović- Petrović RM, Ugrešić N, Prostran MS, Bošković B: The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists. Pain 2004;111:253-260.
5. Vučković SM, Tomić MA, Stepanović- Petroví RM, Ugrešić N, Prostran MS, Bošković B: The effects of alpha(2)-adrenoceptor agents on anti-hyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory pain. Pain 2006;125:10-19.
6. Todorović SM, Rastogi AJ, Jevtović-Todorović V: Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats. Br J Pharmacol 2003;140:255-260.
7. Vučković SM, Tomić MA, Stepanović- Petrović RM, Ugrešić N, Prostran MS, Bošković B: Peripheral antinociception by carbamazepine in an inflammatory mechanical hyperalgesia model in the rat: a new target for carbamazepine? J Pharmacol Sci 2006;100:310-314.
8. 1 receptors. Pharmazie 2006;61:566-568.
9. Tomić MA, Vučković SM, Stepanović- Petrović RM, Ugrešić N, Paranos SLj, Prostran MS, Bošković B: The involvement of peripheral alpha 2-adrenoceptors in the antihyperalgesic effect of oxcarbazepine in a rat model of inflammatory pain. Anesth Analg 2007;105:1474-1481.
10. Marangos PJ, Post RM, Patel J, Zander K, Parma A, Weiss S: Specific and potent interactions of carbamazepine with brain adenosine receptors. Eur J Pharmacol 1983;93:175-182.
11. B receptors are up-regulated by chronic treatment with litium or carbamazepine: GABA hypothesis of affective disorders? Eur J Pharmacol 1989;166:95-99.
12. Foong FW, Satoh M: The periaqueductal gray is the site of the antinociceptive action of carbamazepine as related to bradykinin-induced trigeminal pain. Br J Pharmacol 1984;83:493-497.
13. Kiguchi S, Imamura T, Ichikawa K, Kojima M, Shibata N: Antinociceptive effect of oxcarbazepine (KIN-493/OCBZ) in diabetic animals and its pharmacological properties. Pharmacologist 2002;44:A54.
14. Tallarida RJ, Murray RB: Manual of Pharmacologic Calculations with Computer Programs, ed 2. New York, Springer, 1986.
15. Sawynok J: Topical and peripherally acting analgesics. Pharmacol Rev 2003;55:1-20.
16. Sawynok J: GABAergic mechanisms of analgesia: an update. Pharmacol Biochem Behav 1987;26:463-474.
17. A receptors: evidence for peripheral primary afferent depolarization. Neuroscience 1999;93:713-722.
18. Sawynok J: GABAergic mechanisms in antinociception. Prog Neuropsychopharmacol Biol Psychiatry 1984;8:581-586.
19. Zorn SH, Enna SJ: The effect of mouse spinal cord transection on the antinociceptive response to the γ-aminobutyric acid agonists THIP (4,5,6,7-tetrahydroisoxazolo [5,4-c]pyridine-3-ol) and baclofen. Brain Res 1985;338:380-383.
20. Zonta N, Zambotti I, Vicentini R, Tammiso, Mantagazza P: Effects of some GABA mimetic drugs on the antinociceptive activity of morphine and β-endorphin in rats. Naunyn Schmiedebergs Arch Pharmacol 1981;316:231-234.
21. Zambotti F, Zonta N, Parenti M, Tommasi R, Vicentini L, Conti F, Mantegazza P: Periaqueductal gray matter involvement in the muscimol-induced decrease of morphine antinociception. Naunyn Schmiedebergs Arch Pharmacol 1982;318:368-369.
22. Jasmin L, Rabkin SD, Granato A, Boudah A, Ohara PT: Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature 2003;424:316-320.
23. Mahmoudi M, Zarrindast MR: Effect of intracerebroventricular injection of GABA receptor agents on morphine-induced antinociception in the formalin test. J Psychopharmacol 2002;16:85-91.